Lacosamide for the treatment of epilepsy

References

• Bialer M. New antiepileptic drugs that are second generation to existing antiepileptic drugs. Expert Opin Investig Drugs 2006;15:637–647.
   PubMed Web of Science ®Google Scholar
• Kwan P, Brodie M. Early identification refractory epilepsy. N Engl J Med 2000;342:314–319.
   PubMed Web of Science ®Google Scholar
• Perucca E. Development of new antiepileptic drugs: challenges, incentives, and recent advances. Lancet Neurol 2007;6:793–804.
   PubMed Web of Science ®Google Scholar
• Luszczki JJ. Third-generation antiepileptic drugs: mechanisms of action, pharmacokinetics and interactions. Pharmacol Rep 2009;61:197–216.
   PubMed Web of Science ®Google Scholar
• Choi D, Stables JP, Kohn H. Synthesis and anticonvulsant activities of N-benzyl-2-acetamidopropionamide derivatives. J Med Chem 1996;39:1907–1916.
   PubMed Web of Science ®Google Scholar
• Choi D, Stables JP, Kohn H. The anticonvulsant activities of functionalized N-benzyl 2-acetamidoacetamides. The importance of the 2-acetamido substituent. Bioorg Med Chem 1996;4:2105–2114.
   PubMed Web of Science ®Google Scholar
• Stöhr T, KupferbergHJ, Stables JP . Lacosamide, a novel anti-convulsant drug, shows efficacy with a wide safety margin in rodent models for epilepsy. Epilepsy Res 2007;74:147–154.
   PubMed Web of Science ®Google Scholar
• Stöhr T, Shandra P, Kashenko O . Synergism of lacosamide and first-generation and novel antiepileptic drugs in the 6 Hz seizure model in mice (abstract). Epilepsia 2007;48:252.
   Google Scholar
• Krauss G, Ben-Menachem E, Mameniskiene R Intravenous lacosamide as short-term replacement for oral lacosamide in partial-onset seizures. Epilepsia 2010;51:951–957.
   PubMed Web of Science ®Google Scholar
• Errington AC, Stöhr T, Heers C . The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels. Mol Pharmacol 2008;73:157–169.
   PubMed Web of Science ®Google Scholar
• Errington AC, Coyne L, Stöhr L . Seeking a mechanism of action for the novel anticonvulsant lacosamide. Neuropharmacol 2006;50:1016–1029.
   PubMed Web of Science ®Google Scholar
• Bialer M, Johannessen SI, Kupferberg HJ . Progress report on new antiepileptic drugs: a summary of the Eigth Eilat Conference (EILAT VIII). Epilepsy Res 2007; 73:1–52.
   PubMed Web of Science ®Google Scholar
• Reddy DS. Clinical pharmacokinetic interactions between antiepileptic drugs and hormonal contraceptives. Expert Rev Clin Pharmacol 2010;3:183–192.
   PubMedGoogle Scholar
• Ben-Manachem E, Biton V, Jatuzis D Efficacy and safety of oral lacosmide as adjunctive therapy in adults with partial-onset seizures. Epilepsia 2007;481308–1317.
   Google Scholar
• Halasz P, Kalviainen R, Mazurkiewicz-Beldzinska M . Adjuntive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial. Epilepsia 2009;50:443–453.
   PubMed Web of Science ®Google Scholar
• Chung S, Sperling MR, Biton V . Lacosamide as adjunctive therapy for partial-onset seizures: A randomized controlled trial. Epilepsia 2010;51:958–967.
   PubMed Web of Science ®Google Scholar
• Isojarvi J, Rosenow F, Faught E, Hebert D, Doty P (2009) Efficacy of lacosamide in partial-onset seizures with and without secondary generalization: A pooled analysis of three phase II/III trials. Epilepsia. 50(suppl s10):112 (abs p515).
   Google Scholar
• Chen L, Haneef Z, Dorsch A Successful treatment of refractory simple motor status epilepticus with lacosamide and levetiracetam. Seizure: European Journal of Epilepsy 2011;20:263–5.
   PubMedGoogle Scholar
• Fountain NB, Krauss G, Isojarvi J, Dilley D, Doty P, Rudd GD. A multicenteropen-label trial to assess the safety and tolerability of a single intravenous loading dose of lacosamide followed by oral maintenance as adjunctive therapy in patients with partial-onset seizures. European Congress on Epileptology – 9th. Epilepsia. 2010;51(Suppl. 4):123 (abs p416).
   Google Scholar
• Albers JM, Möddel G, Dittrich R, Intravenous lacosamide-an effective add-on treatment of refractory status epilepticus. Seizures 2011 (article in press).
   Google Scholar
• Edwards HB, Cole AG Minimizing pharmacodynamic interaction of high doses of lacosamide. Acta Neurol Scand 2011;[Epub ahead of print].
   Google Scholar
• Sake J, Herbert D, Isojarvi J A pooled analysis of lacosamide clinical trial data grouped by mechanism of action of concomitant antiepileptic drugs. CNS Drugs 2010;24: 1055–1068.
   PubMed Web of Science ®Google Scholar
• Novy J, Patsalos PN, Sander JW, Lacosamide neurotoxicity associated with concomitant use of sodium channel-blocking antiepileptic drugs: A pharmacodynamic interaction? Epilepsy Behav 2011;20:20–23.
   PubMed Web of Science ®Google Scholar